论文部分内容阅读
骨肉瘤是危害人类健康,尤其是青少年健康的严重疾病。虽然发病率不高,但死亡率高,社会危害大。如何更好地治疗骨肉瘤一直是骨科医生面临的重大挑战。近20年来,随着新辅助化疗和保肢等新技术的临床应用,患者的5年生存率和生存质量已有了明显提高。近些年来,骨肉瘤发病率有逐年上升趋势,医生在治疗该病过程中存在着不足与差异。为了进一步规范骨肉瘤的治疗,提高诊疗水平,为国内外学者提供良好的学术交流平台,拟定于2012年9月14-16日在上海举行第二届骨肉瘤保肢治疗新进展高级研讨会。
Osteosarcoma is a serious disease that endangers human health, especially adolescent health. Although the incidence is not high, but the high mortality rate, social harm. How to better treat osteosarcoma has been a major challenge for orthopedic surgeons. In recent 20 years, with the clinical application of new technologies such as neoadjuvant chemotherapy and limb salvage, the 5-year survival rate and quality of life of patients have been significantly improved. In recent years, the incidence of osteosarcoma has increased year by year, doctors in the treatment of the disease there are deficiencies and differences. In order to further standardize the treatment of osteosarcoma and improve the level of diagnosis and treatment, it provides a good academic exchange platform for domestic and foreign scholars and plans to hold the 2nd Advanced Seminar on the New Progress of Limb Salvage Limb Salvage in Shanghai from September 14 to September 16, 2012.